PD158780
CAS No. 171179-06-9
PD158780 ( —— )
Catalog No. M20133 CAS No. 171179-06-9
PD 158780 reversibly inhibits auto and transphosphorylation of all four members of the ErbB receptor superfamily: EGFR ErbB2 ErbB3 and ErbB4 (IC50s: 8μM 49 nM 52 nM and 52 nM in cell assay).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 69 | In Stock |
|
10MG | 110 | In Stock |
|
25MG | 205 | In Stock |
|
50MG | 357 | In Stock |
|
100MG | 524 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePD158780
-
NoteResearch use only not for human use.
-
Brief DescriptionPD 158780 reversibly inhibits auto and transphosphorylation of all four members of the ErbB receptor superfamily: EGFR ErbB2 ErbB3 and ErbB4 (IC50s: 8μM 49 nM 52 nM and 52 nM in cell assay).
-
DescriptionPD 158780 reversibly inhibits auto and transphosphorylation of all four members of the ErbB receptor superfamily: EGFR ErbB2 ErbB3 and ErbB4 (IC50s: 8μM 49 nM 52 nM and 52 nM in cell assay).
-
Synonyms——
-
PathwayAngiogenesis
-
TargetEGFR
-
RecptorEGFR; ErbB2; ErbB3; ErbB4
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number171179-06-9
-
Formula Weight330.19
-
Molecular FormulaC14H12BrN5
-
Purity>98% (HPLC)
-
SolubilityDMSO: 30 mg/mL (90.86 mM);Ethanol: 8 mg/mL (24.23 mM)
-
SMILESCNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1
-
Chemical Name4-N-(3-bromophenyl)-6-N-methylpyrido[34-d]pyrimidine-46-diamine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Fry DW et al. Biochemical and antiproliferative properties of 4-[ar(alk)ylamino]pyridopyrimidines a new chemical class of potent and specific epidermal growth factor receptor tyrosine kinase inhibitor. Biochem Pharmacol. 1997 Oct 15;54(8):877-87.
molnova catalog
related products
-
Almonertinib mesylat...
Almonertinib mesylate is an irreversible inhibitor of EGFR tyrosine kinase with high selectivity for EGFR-sensitizing and T790M resistance mutations. Almonertinib mesylate can be used in the non-small cell lung cancer studies.
-
Vandetanib
Vandetanib is an orally bioavailable 4-anilinoquinazoline. Vandetanib selectively inhibits the tyrosine kinase activity of vascular endothelial growth factor receptor 2 (VEGFR2), thereby blocking VEGF-stimulated endothelial cell proliferation and migration and reducing tumor vessel permeability.
-
Piperonyl butoxide(b...
Piperonyl butoxide is an insecticide synergist, particularly for rotenone and pyrethroids.